How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Preclinical Animal Telemetry Market
- By Animal Model Type: Rodents, Non-human Primates, Canines, Swine, Rabbits
- By Telemetry System Type: Implantable Telemetry Systems, External Telemetry Systems, Hybrid Telemetry Systems
- By Physiological Parameters Monitored: Cardiovascular Monitoring, Respiratory Monitoring, Neurological Monitoring, Metabolic Monitoring, Temperature Monitoring
- By End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), Government & Regulatory Agencies
- By Data Transmission Technology: Radio Frequency (RF) Telemetry, Bluetooth Telemetry, Infrared Telemetry, Ultrasonic Telemetry
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Rodents leads By Animal Model Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 12 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 12 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Preclinical Animal Telemetry Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 12 company profiles, forecast to 2033.
Segmentation covered
Animal Model Type 5
Telemetry System Type 3
Physiological Parameters Monitored 5
End User 4
Data Transmission Technology 4
Companies profiled
Data Sciences International (DSI)
Biopac Systems Inc.
Emka Technologies
Notocord Systems
Harvard Apparatus
ADInstruments
Millar Inc.
Panlab Harvard Apparatus
Kaha Sciences
Instech Laboratories
Radiometer Medical ApS
Transoma Medical
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
12 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Data Sciences International (DSI)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Biopac Systems Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Emka Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Notocord Systems
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Harvard Apparatus
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →ADInstruments
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Millar Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Panlab Harvard Apparatus
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Kaha Sciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Instech Laboratories
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Radiometer Medical ApS
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Transoma Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,398M by 2033 · 10.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Rodents30.6
- Non-human Primates15.9
- Canines22.7
- Swine12.0
- Rabbits18.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$802.4M → $1,669M · 9.6%
Europe$559.3M → $1,148M · 9.4%
Asia Pacific$510.6M → $1,123M · 10.4%
Latin America$316.1M → $752.7M · 11.5%
Middle East and Africa$243.2M → $579.4M · 11.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.442026
10.442027
10.472028
10.462029
10.492030
10.492031
10.502032
10.512033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Data Sciences International (DSI)25.1
- Biopac Systems Inc.12.1
- Emka Technologies14.3
- Notocord Systems6.5
- Harvard Apparatus5.8
- ADInstruments8.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Animal Model Type20.3%
Telemetry System Type25.1%
Physiological Parameters Monitored15.7%
End User13.3%
Data Transmission Technology25.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.7
- Europe21.8
- Asia Pacific21.3
- Latin America14.3
- Middle East and Africa11.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Data Sciences International (DSI) | 92 | 78 | 75 | 95 | 94 | 82 | 86 |
| Biopac Systems Inc. | 78 | 77 | 76 | 79 | 72 | 88 | 78 |
| Emka Technologies | 66 | 78 | 63 | 67 | 83 | 66 | 71 |
| Notocord Systems | 65 | 75 | 81 | 58 | 68 | 76 | 71 |
| Harvard Apparatus | 69 | 72 | 75 | 77 | 53 | 70 | 69 |
| ADInstruments | 68 | 54 | 68 | 61 | 46 | 58 | 59 |
| Millar Inc. | 54 | 58 | 62 | 42 | 42 | 50 | 51 |
| Panlab Harvard Apparatus | 36 | 54 | 36 | 48 | 40 | 57 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Data Sciences International (DSI)
- Biopac Systems Inc.
- Emka Technologies
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Data Sciences International (DSI) | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Biopac Systems Inc. | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Emka Technologies | − | ✓ | ◐ | ◐ | ✓ | − |
| Notocord Systems | − | ✓ | ✓ | ◐ | ✓ | ✓ |
| Harvard Apparatus | ✓ | ◐ | − | ◐ | ◐ | ◐ |
| ADInstruments | ◐ | − | ◐ | ◐ | − | − |
| Millar Inc. | − | − | − | − | ◐ | − |
| Panlab Harvard Apparatus | − | ◐ | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Data Sciences International (DSI)86
2Biopac Systems Inc.78
3Emka Technologies71
4Notocord Systems71
5Harvard Apparatus69
6ADInstruments59
7Millar Inc.51
8Panlab Harvard Apparatus45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Data Sciences International (DSI)Biopac Systems Inc.
Challenger3
Strong scale, closing on the leaders.
Emka TechnologiesNotocord SystemsHarvard Apparatus
Contender1
Focused players with pockets of strength.
ADInstruments
Niche2
Specialists in a single segment or region.
Millar Inc.Panlab Harvard Apparatus
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Animal Model Type in North America, then scale across Preclinical Animal Telemetry Market — a $335M beachhead inside a $6.07B market.
Beachhead (SOM)$335Mobtainable near-term
Serviceable (SAM)$2.10Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Rodents
Best fit — highest urgency & budget in Animal Model Type.
Economic buyer79 fit
Non-human Primates
Strong fit — clear ROI and a fast path to value.
End user67 fit
Canines
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Animal Model Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Telemetry System Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Physiological Parameters Monitored
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel29%
Digital / self-serve21%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Animal Model Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Preclinical Animal Telemetry Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified24%
Evaluation11%
Closed-won6%
$8.4KCAC
$38KLTV
4.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Preclinical Animal Telemetry Market is a durable-growth opportunity — $3.17B by 2033, compounding at 6.2%.
TAM · 2025$1.96Btoday
TAM · 2033$3.17Bforecast
CAGR6.2%2027–2033
Cumulative$22.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.17BTotal addressable market
SAM$1.15BServiceable available market
SOM$233MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.2% CAGR
Demand compounds through 2033, outpacing GDP across Animal Model Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Animal Model Type moving from early to mainstream — durable secular demand.
Consolidation upside
12+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.17BLarge & growingTAM by 2033 at 6.2% CAGR
$1.15BServiceable nowreachable with today’s model
$233MBeachhead winobtainable near-term share
12+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.47BBear4.0% CAGR
$3.17BBase6.2% CAGR
$4.05BBull8.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Telemetry System Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Preclinical Animal Telemetry Market — a $10.4B market by 2033. Plan: grow share from 8.3% to 15.0%.
Market size · 2033$10.4Btotal addressable
Market CAGR9.6%2027–2033
Target share15.0%from 8.3% today
Revenue ambition$1.57Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.3% | 15.0% | At risk |
| Revenue | $930M | $1.57B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 37.6% | 44.2% | Ahead |
| Customer retention | 89.3% | 95.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Animal Model Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Telemetry System Type capability
A defensible second engine — invest in Telemetry System Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Animal Model Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Telemetry System Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $211M capacity & capability investment
- Greenlight bolt-on M&A in Telemetry System Type
- Authorise North America expansion plan
- Fund R&D program for Animal Model Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAhead
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Preclinical Animal Telemetry Market conversation — a $8.01B market you can size, segment and defend in minutes.
Market size · 2033$8.01Btotal opportunity
Growth8.2%CAGR to 2033
Addressable buyers1,216+accounts in scope
Typical ROI5.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Animal Model Type
Goal Grow share in Animal Model Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.4×return on cost, year one
< 4 mopayback period
$100K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
12+players profiled in this market
Coverage includes
Data Sciences International (DSI)Biopac Systems Inc.Emka TechnologiesNotocord SystemsHarvard ApparatusADInstrumentsMillar Inc.Panlab Harvard Apparatus+4 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Preclinical Animal Telemetry Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Preclinical Animal Telemetry Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Preclinical Research Service Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportPre-Coat Filter Market
Market size, share, segmentation and regional forecast.
$852M market · 2025 base year
View reportPre-coated Metal Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportPrecoated Zinc-Coated Carbon Steel Sheet Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportPre-Cooling Machine Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportPrecursor Bubbler Cylinder Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportPre-Curved Concrete Beam Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportPredictive Analytics for BFSI Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportPredictive Breast Cancer Gene Testing Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportPredictive Genetic Testing & Consumer/Wellness Genomics Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportPredictive Maintenance (PdM) in Aerospace Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportPredictive Maintenance (PdM) Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.